Hiroshi Ohtsu Selected Research

Hiroshi Ohtsu Research Topics

Disease

12	Inflammation (Inflammations) 10/2017 - 10/2002
11	Hypersensitivity (Allergy) 12/2019 - 06/2002
7	Hypertension (High Blood Pressure) 11/2021 - 10/2006
7	Anaphylaxis (Anaphylactic Shock) 01/2018 - 08/2002
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 01/2011
6	Chronic Renal Insufficiency 01/2019 - 06/2010
5	Atherosclerosis 04/2011 - 05/2005
4	COVID-19 10/2022 - 10/2021
4	Neoplasms (Cancer) 02/2022 - 10/2014
4	Hyperplasia 01/2018 - 03/2008
4	Asthma (Bronchial Asthma) 01/2010 - 03/2003
3	Narcolepsy 01/2021 - 12/2013
3	Heart Failure 11/2020 - 08/2012
3	Breast Neoplasms (Breast Cancer) 03/2020 - 02/2016
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 04/2013
3	Albuminuria 01/2019 - 06/2010
3	Proteinuria 12/2018 - 01/2012
3	Tics (Tic) 11/2018 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 03/2008
3	Cataplexy 10/2016 - 12/2013
3	Ischemia 02/2012 - 03/2010
3	Atrial Fibrillation 04/2011 - 10/2006
3	Eosinophilia 01/2010 - 03/2003
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2009 - 01/2006
3	Contact Dermatitis (Eczema, Contact) 01/2009 - 08/2005
2	Pathologic Constriction (Stenosis) 11/2021 - 08/2013
2	Obesity 11/2021 - 01/2015
2	Wounds and Injuries (Trauma) 11/2020 - 06/2006
2	Sepsis (Septicemia) 10/2019 - 12/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 09/2011
2	Dermatitis 01/2017 - 10/2006
2	Pain (Aches) 01/2016 - 09/2013
2	Neuralgia (Stump Neuralgia) 01/2016 - 06/2013
2	Lymphedema (Milroy Disease) 10/2015 - 04/2013
2	Tourette Syndrome (Tourette's Syndrome) 05/2015 - 01/2014
2	Allergic Contact Dermatitis 04/2015 - 09/2012
2	Hypertrophy 08/2012 - 03/2011
2	Ventricular Tachycardia 02/2012 - 03/2006
2	Communicable Diseases (Infectious Diseases) 01/2012 - 01/2010
2	Infarction (Infarctions) 01/2011 - 03/2010
2	Necrosis 06/2010 - 10/2002
2	Malaria 04/2009 - 02/2008
2	Disease Progression 09/2008 - 01/2006

Drug/Important Bio-Agent (IBA)

51	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 06/2002
21	Histidine DecarboxylaseIBA 11/2020 - 08/2002
9	Histamine Receptors (Histamine Receptor)IBA 11/2020 - 01/2006
7	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2016 - 10/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 01/2011
5	Histidine (L-Histidine)FDA Link 01/2016 - 03/2003
4	OrexinsIBA 01/2021 - 12/2013
4	AldosteroneIBA 01/2019 - 06/2010
4	NickelIBA 01/2016 - 01/2009
4	Immunoglobulin E (IgE)IBA 11/2015 - 08/2002
4	AntigensIBA 12/2013 - 10/2002
3	pitavastatin (itavastatin)FDA Link 10/2022 - 01/2018
3	Angiotensin Receptor AntagonistsIBA 10/2022 - 04/2011
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019 - 06/2010
3	CreatinineIBA 12/2018 - 06/2010
3	Trefoil FactorsIBA 01/2018 - 09/2011
3	InterleukinsIBA 08/2017 - 02/2009
3	CytokinesIBA 12/2016 - 02/2009
3	Mineralocorticoid Receptor AntagonistsIBA 01/2016 - 06/2010
3	CarnosineIBA 02/2015 - 04/2007
3	EnzymesIBA 09/2011 - 08/2002
3	Amlodipine (Norvasc)FDA LinkGeneric 04/2011 - 10/2006
3	IonsIBA 04/2011 - 01/2009
2	LDL CholesterolIBA 10/2022 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022 - 12/2014
2	LipidsIBA 10/2022 - 03/2018
2	Blood Glucose (Blood Sugar)IBA 04/2022 - 05/2012
2	AnticoagulantsIBA 11/2021 - 10/2021
2	Histamine Antagonists (Antihistamines)IBA 01/2021 - 08/2002
2	Pharmaceutical PreparationsIBA 05/2020 - 12/2013
2	SaltsIBA 01/2019 - 01/2012
2	Pepsinogen A (Pepsinogen)IBA 01/2018 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2016 - 08/2012
2	CalciumIBA 01/2016 - 10/2006
2	Pyrilamine (Mepyramine)FDA Link 01/2016 - 10/2002
2	AllergensIBA 11/2015 - 03/2003
2	Histamine H2 ReceptorsIBA 05/2015 - 10/2002
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015 - 02/2012
2	Eplerenone (Inspra)FDA LinkGeneric 12/2014 - 06/2010
2	AlbuminsIBA 12/2014 - 06/2010
2	Immunoglobulin G (IgG)IBA 09/2011 - 04/2009
2	ApolipoproteinsIBA 04/2011 - 05/2005
2	LipopolysaccharidesIBA 04/2011 - 09/2004
2	candesartanIBA 04/2011 - 10/2006
2	MetalsIBA 04/2011 - 01/2009
2	CholesterolIBA 04/2011 - 05/2005
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2011 - 03/2011
2	Angiotensin II Type 1 Receptor BlockersIBA 03/2011 - 10/2006
2	Proteins (Proteins, Gene)FDA Link 01/2011 - 06/2006
2	AminesIBA 04/2009 - 02/2008

Therapy/Procedure

14	Therapeutics 10/2022 - 03/2006
2	Drug Therapy (Chemotherapy) 02/2022 - 01/2014
2	Glycemic Control 01/2022 - 05/2012
2	Surgical Decompression 11/2021 - 08/2013
2	Ligation 01/2016 - 10/2003
2	Transcranial Magnetic Stimulation 04/2013 - 04/2013